131 related articles for article (PubMed ID: 17240507)
1. Anserine induced advantage effects on the antitumor activity of doxorubicin.
Sadzuka Y; Sonobe T
Food Chem Toxicol; 2007 Jun; 45(6):985-9. PubMed ID: 17240507
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of doxorubicin concentration in the M5076 ovarian sarcoma cells by cucurbitacin E co-treatment.
Sadzuka Y; Hatakeyama H; Sonobe T
Int J Pharm; 2010 Jan; 383(1-2):186-91. PubMed ID: 19732815
[TBL] [Abstract][Full Text] [Related]
3. Screening of biochemical modulator by tumor cell permeability of doxorubicin.
Sadzuka Y; Hatakeyama H; Daimon T; Sonobe T
Int J Pharm; 2008 Apr; 354(1-2):63-9. PubMed ID: 18054183
[TBL] [Abstract][Full Text] [Related]
4. Increased effects of MPDAX, a novel xanthine derivative, on antitumor activity of doxorubicin.
Sadzuka Y; Sugiyama T; Suzuki H; Sawanishi H; Miyamoto K
Toxicol Lett; 2004 May; 150(3):341-9. PubMed ID: 15110086
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin.
Sadzuka Y; Nagamine M; Toyooka T; Ibuki Y; Sonobe T
Int J Pharm; 2012 Aug; 432(1-2):42-9. PubMed ID: 22569233
[TBL] [Abstract][Full Text] [Related]
6. Effects of glutamate transporter inhibitors on the antitumor activity of doxorubicin.
Sadzuka Y; Yamashita Y; Sonobe T
Clin Cancer Res; 2002 Dec; 8(12):3943-7. PubMed ID: 12473610
[TBL] [Abstract][Full Text] [Related]
7. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of theanine is connected with theanine metabolism by any enzyme, not only drug metabolizing enzymes.
Sadzuka Y; Sugiyama T; Nagamine M; Umegaki K; Sonobe T
Food Chem Toxicol; 2006 Feb; 44(2):286-92. PubMed ID: 16140449
[TBL] [Abstract][Full Text] [Related]
9. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
Garde SV; Forté AJ; Ge M; Lepekhin EA; Panchal CJ; Rabbani SA; Wu JJ
Anticancer Drugs; 2007 Nov; 18(10):1189-200. PubMed ID: 17893520
[TBL] [Abstract][Full Text] [Related]
10. Proanthocyanidin from grape seeds enhances doxorubicin-induced antitumor effect and reverses drug resistance in doxorubicin-resistant K562/DOX cells.
Zhang XY; Li WG; Wu YJ; Bai DC; Liu NF
Can J Physiol Pharmacol; 2005 Mar; 83(3):309-18. PubMed ID: 15870845
[TBL] [Abstract][Full Text] [Related]
11. Proanthocyanidin from grape seeds potentiates anti-tumor activity of doxorubicin via immunomodulatory mechanism.
Zhang XY; Li WG; Wu YJ; Zheng TZ; Li W; Qu SY; Liu NF
Int Immunopharmacol; 2005 Jul; 5(7-8):1247-57. PubMed ID: 15914329
[TBL] [Abstract][Full Text] [Related]
12. Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: a flow cytometric study.
Zaleskis G; Ho RL; Diegelman P; Maccubbin D; Ujházy P; Mihich E; Ehrke MJ
Oncol Res; 1994; 6(4-5):183-94. PubMed ID: 7841541
[TBL] [Abstract][Full Text] [Related]
13. Effect of linalool as a component of Humulus lupulus on doxorubicin-induced antitumor activity.
Miyashita M; Sadzuka Y
Food Chem Toxicol; 2013 Mar; 53():174-9. PubMed ID: 23220514
[TBL] [Abstract][Full Text] [Related]
14. [The effect of finoptin on the accumulation of doxorubicin in leukemia P388 cells with induced resistance to the antibiotic].
Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM
Biull Eksp Biol Med; 1989 Dec; 108(12):714-6. PubMed ID: 2634447
[TBL] [Abstract][Full Text] [Related]
15. In vivo reversal of doxorubicin resistance by (-)-epigallocatechin gallate in a solid human carcinoma xenograft.
Zhang Q; Wei D; Liu J
Cancer Lett; 2004 May; 208(2):179-86. PubMed ID: 15142676
[TBL] [Abstract][Full Text] [Related]
16. A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapy.
de Graaf M; Nevalainen TJ; Scheeren HW; Pinedo HM; Haisma HJ; Boven E
Biochem Pharmacol; 2004 Dec; 68(11):2273-81. PubMed ID: 15498517
[TBL] [Abstract][Full Text] [Related]
17. Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma.
Sugiyama T; Sadzuka Y
Clin Cancer Res; 1999 Feb; 5(2):413-6. PubMed ID: 10037191
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effect of doxorubicin combined with liposome-encapsulated muramyl tripeptide on canine monocyte activation.
Shi F; MacEwen EG; Kurzman ID
Cancer Res; 1993 Sep; 53(17):3986-91. PubMed ID: 8358727
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bio-nanoparticles as drug carriers.
Sun JB; Duan JH; Dai SL; Ren J; Zhang YD; Tian JS; Li Y
Cancer Lett; 2007 Dec; 258(1):109-17. PubMed ID: 17920762
[TBL] [Abstract][Full Text] [Related]
20. Preclinical models of cardiac protection and testing for effects of dexrazoxane on doxorubicin antitumor effects.
Imondi AR
Semin Oncol; 1998 Aug; 25(4 Suppl 10):22-30. PubMed ID: 9768820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
